Literature DB >> 18516514

Kraepelin, biological psychiatry, and beyond.

Hermann M van Praag1.   

Abstract

One of Kraepelin's major contributions has been the introduction of the nosological principle in psychiatry. Mental pathology, he presumed, is subdividable in discrete entities each based on a specific pathophysiology. Kraepelin provided the diagnostic process in psychiatry with a solid infrastructure. It has been used in biological psychiatric research until this very day. Searching for the biological determinants of categorical entities has been its major goal. The yield of those efforts has been meagre, in that none of the biological findings reported so far seemed to be specific for a particular nosological entity. The question thus arises: is nosology the right model to classify mental disorders. It is suggested that it is not. The disease categories presently delineated are utterly heterogeneous, and therefore cannot be expected to have a well-defined pathophysiology. The nosological system cannot be rejected (as yet), but it has to be upgraded by incorporation of a strong dynamic-functional component. The functional components should become the focus of biological psychiatric research. The question whether an alternative classificatory model, such as the reaction form model, has to be preferred in biological psychiatry should become a matter of serious discussion.

Entities:  

Mesh:

Year:  2008        PMID: 18516514     DOI: 10.1007/s00406-008-2006-1

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  7 in total

1.  Nosologomania: a disorder of psychiatry.

Authors:  H M van Praag
Journal:  World J Biol Psychiatry       Date:  2000-07       Impact factor: 4.132

Review 2.  The discovery of susceptibility genes for mental disorders.

Authors:  C Robert Cloninger
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-08       Impact factor: 11.205

3.  Schizophrenia genes - famine to feast.

Authors:  Richard E Straub; Daniel R Weinberger
Journal:  Biol Psychiatry       Date:  2006-07-15       Impact factor: 13.382

4.  Rethinking psychosis: the disadvantages of a dichotomous classification now outweigh the advantages.

Authors:  Nick Craddock; Michael J Owen
Journal:  World Psychiatry       Date:  2007-06       Impact factor: 49.548

5.  About the impossible concept of schizophrenia.

Authors:  H M van Praag
Journal:  Compr Psychiatry       Date:  1976 Jul-Aug       Impact factor: 3.735

Review 6.  Anxiety/aggression--driven depression. A paradigm of functionalization and verticalization of psychiatric diagnosis.

Authors:  H M Van Praag
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2001-05       Impact factor: 5.067

Review 7.  Genes for schizophrenia? Recent findings and their pathophysiological implications.

Authors:  Paul J Harrison; Michael J Owen
Journal:  Lancet       Date:  2003-02-01       Impact factor: 79.321

  7 in total
  9 in total

1.  DSM diagnosis and beyond: on the need for a hermeneutically-informed biopsychosocial framework.

Authors:  Paul Healy
Journal:  Med Health Care Philos       Date:  2011-05

2.  [The Research Domain Criteria (Rdoc), reductionism and clinical psychiatry].

Authors:  Luc Faucher; Simon Goyer
Journal:  Rev Synth       Date:  2016-12

3.  The association of cognitive and somatic depressive symptoms with depression recognition and outcomes after myocardial infarction.

Authors:  Kim G Smolderen; John A Spertus; Kimberly J Reid; Donna M Buchanan; Harlan M Krumholz; Johan Denollet; Viola Vaccarino; Paul S Chan
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2009-04-25

4.  The ADHD-200 Consortium: A Model to Advance the Translational Potential of Neuroimaging in Clinical Neuroscience.

Authors: 
Journal:  Front Syst Neurosci       Date:  2012-09-05

5.  A New Approach to Investigate the Association between Brain Functional Connectivity and Disease Characteristics of Attention-Deficit/Hyperactivity Disorder: Topological Neuroimaging Data Analysis.

Authors:  Sunghyon Kyeong; Seonjeong Park; Keun-Ah Cheon; Jae-Jin Kim; Dong-Ho Song; Eunjoo Kim
Journal:  PLoS One       Date:  2015-09-09       Impact factor: 3.240

6.  The influence of 5-HTTLPR genotype on the association between the plasma concentration and therapeutic effect of paroxetine in patients with major depressive disorder.

Authors:  Tetsu Tomita; Norio Yasui-Furukori; Taku Nakagami; Shoko Tsuchimine; Masamichi Ishioka; Ayako Kaneda; Norio Sugawara; Sunao Kaneko
Journal:  PLoS One       Date:  2014-05-23       Impact factor: 3.240

7.  A population-based study of KCNH7 p.Arg394His and bipolar spectrum disorder.

Authors:  Kevin A Strauss; Sander Markx; Benjamin Georgi; Steven M Paul; Robert N Jinks; Toshinori Hoshi; Ann McDonald; Michael B First; Wencheng Liu; Abigail R Benkert; Adam D Heaps; Yutao Tian; Aravinda Chakravarti; Maja Bucan; Erik G Puffenberger
Journal:  Hum Mol Genet       Date:  2014-06-30       Impact factor: 6.150

8.  Sex differences in the prediction of the effectiveness of paroxetine for patients with major depressive disorder identified using a receiver operating characteristic curve analysis for early response.

Authors:  Tetsu Tomita; Norio Yasui-Furukori; Yasui-Furukori Norio; Yasushi Sato; Taku Nakagami; Shoko Tsuchimine; Ayako Kaneda; Sunao Kaneko
Journal:  Neuropsychiatr Dis Treat       Date:  2014-04-08       Impact factor: 2.570

9.  Metabolomic biosignature differentiates melancholic depressive patients from healthy controls.

Authors:  Yashu Liu; Lynn Yieh; Tao Yang; Wilhelmus Drinkenburg; Pieter Peeters; Thomas Steckler; Vaibhav A Narayan; Gayle Wittenberg; Jieping Ye
Journal:  BMC Genomics       Date:  2016-08-23       Impact factor: 3.969

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.